The voice of Scotland’s life sciences industries
Members’ area
5 Mar 2025
The SLA has signed a MoU with ABLE in India to promote member-member interactions between Scotland and India. To access a copy of the MoU please contact Scott@sla.scot
Read story26 Feb 2025
BioAscent, a leading provider of integrated drug discovery and compound management services, has reported a strong pipeline of new projects for the year ahead, after a challenging year across the sector.
Read story19 Feb 2025
Kelso Pharma, the growing specialty pharma business backed by Apposite Capital, the healthcare specialist private equity investor, today (19 February 2025) announces the acquisition of the UK pharma business, ALTURiX Ho…
Read story15 Jan 2025
The Indiana Life Sciences Association announced today that, after several fact-finding trips, Sanondaf Touch-Less Disinfection Services has chosen Indianapolis as its’ U.S. headquarters with plans to expand sales nation…
Read story14 Nov 2024
AM Sci Tech, a subsidiary of Hurstwood Holdings is pleased to announce the appointment of Gordon Pirie as Asset Manager at Aberdeen Energy & Innovation Parks.
Read story5 Nov 2024
BioAscent awarded prestigious Knowledge Transfer Partnership with Centre for Targeted Protein Degradation at the University of Dundee.
Read story21 Oct 2024
The investment in diagnostics and blood typing will allow the company to increase its production capacity of diagnostic monoclonal antibodies (mAbs) by approximately 35 per cent. mAbs are used by health and science prof…
Read story14 Sep 2024
NuCana plc (NASDAQ: NCNA) presented final data from the Phase 2 NuTide:701 study at the ESMO Congress on NUC-7738 in combination with pembrolizumab for patients with metastatic melanoma who were refractory to or had rel…
Read story26 Jul 2024
Medannex today announced an Innovate UK grant to fund a £313,000 project developing a new treatment for paediatric osteosarcoma. The ‘Transforming Cancer Therapeutics’ award will allow the Scottish biotech company to pr…
Read story1 Jun 2024
Medannex Ltd (Edinburgh) today revealed details of the ATTAINMENT study at the American Society of Clinical Oncology (ASCO) Annual Meeting.
Read story29 Apr 2024
Nebu-Flow has secured an additional £4.7 million of investment to accelerate the next generation of inhaled drugs for patients with respiratory disorders, which are the main cause of death and disability worldwide.
Read story8 Apr 2024
(Newhouse, UK, 8 April 2024) Integrated drug discovery services provider BioAscent, which marked its tenth anniversary in 2023, has reported promising growth in the wake of sustained demand for its services.
Read story4 Apr 2024
EnteroBiotix Limited, a clinical-stage biotechnology company focussed on developing best-in-class full-spectrum microbiome therapeutics, today announced that the Company has completed its £27m ($34m USD) funding round, …
Read story30 Mar 2024
Edinburgh-based biotechnology firm, CALCIVIS®, has secured £5m in funding to roll out its cutting-edge dental technology.
Read story18 Mar 2024
First-in-class therapy now patent-protected in all major markets, including USA, Europe, China, Japan and Canada
Read story